Vinflunine plus capecitabine for advanced breast cancer previously treated with or resistant to anthracycline and resistant to taxane: A phase III study versus capecitabine.

被引：0
|
作者：
Aapro, Matti S.
Demidchik, Yuri
Bondarenko, Igor
Siedakov, Igor
Sakaeva, Dina
Krishnamurthy, S.
Roman, Laslo
Lebedeva, Liudmila
Mefti, Fawzia
Ponomarova, Olga
Bachelot, Thomas Denis
Lytvyn, Lryna
Delaloge, Suzette
Kupp, Anita
Karchmit, Yauheniya
Bougnoux, Philippe
Campone, Mario
Martin, Miguel
机构：
[1] Clin Genolier, Genolier, Switzerland
[2] Belarusian Med Acad Postgrad Educ, Minsk, BELARUS
[3] Dnipropetrovsk City Multifield Clin Hosp 4, Dnepropetrovsk, Ukraine
[4] Reg Antitumor Ctr, Donetsk, Ukraine
[5] Republican Clin Oncol Dispensary, Ufa, Russia
[6] Kidway Mem Inst Oncol, Bangalore, Karnataka, India
[7] Leningrad Reg Oncol Dispensary, St Petersburg, Russia
[8] Clin Oncol Dispensary, Arkhangelsk, Russia
[9] Hop Rene Huguenin, Inst Curie, St Cloud, France
[10] City Oncol Hosp, Kiev, Ukraine
[11] Ctr Leon Berard, Dept Oncol Med, F-69373 Lyon, France
[12] Reg Oncol Hosp, Dnepropetrovsk, Ukraine
[13] Inst Cancerol Gustave Roussy, Villejuif, France
[14] North Estonia Med Ctr, Tallinn, Estonia
[15] Reg Clin Oncol Dispensary, Vitebsk, BELARUS
[16] CHU Bretonneau, Dept Med Oncol, F-37044 Tours, France
[17] Inst Cancerol Ouest, Nantes, France
[18] Hosp Univ Gregorio Maranon, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.1013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1013
引用
收藏
页数：1
相关论文
共 50 条
  • [1] VINFLUNINE (VFL) PLUS CAPECITABINE (CAPE) FOR ADVANCED BREAST CANCER (ABC) PREVIOUSLY TREATED WITH OR RESISTANT TO ANTHRACYCLINE AND RESISTANT TO TAXANE : A PHASE 3 STUDY VERSUS CAPECITABINE
    Martin, M.
    Demidchik, Y.
    Bondarenko, I.
    Siedakov, I.
    Sakaeva, D.
    Krishnamurthy, S.
    Roman, L.
    Lebedeva, L.
    Mefti, F.
    Bachelot, T.
    Ponomarova, O.
    Delaloge, S.
    Lytvyn, I.
    Kupp, A.
    Karchmit, Y.
    Bougnoux, P.
    Campone, M.
    Aapro, M. S.
    ANNALS OF ONCOLOGY, 2014, 25
  • [2] Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane
    Martin, M.
    Campone, M.
    Bondarenko, I
    Sakaeva, D.
    Krishnamurthy, S.
    Roman, L.
    Lebedeva, L.
    Vedovato, J-C
    Aapro, M.
    ANNALS OF ONCOLOGY, 2018, 29 (05) : 1195 - 1202
  • [3] Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
    Sparano, Joseph A.
    Vrdoljak, Eduard
    Rixe, Oliver
    Xu, Binghe
    Manikhas, Alexey
    Medina, Carlos
    Ventilari Da Costa, Susanne Crocamo
    Ro, Jungsil
    Rubio, Gonzalo
    Rondinon, Monica
    Perez Manga, Gumersindo
    Peck, Ronald
    Poulart, Valerie
    Conte, Pierfranco
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : 3256 - 3263
  • [4] Phase III trial of ixabepilone plus capecitabine compared to capecitabine alone in patients with metastatic breast cancer (MBC) previously treated or resistant to an anthracycline and resistant to taxanes
    Vahdat, L. T.
    Thomas, E.
    Li, R.
    Jassem, J.
    Gomez, H.
    Chung, H.
    Peck, R.
    Mukhopadhyay, P.
    Klimovsky, J.
    Roche, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Phase II trial of ixabepilone in patients with metastatic breast cancer (MBC) who are resistant to an anthracycline, a taxane and capecitabine.
    Thomas, E.
    Perez, E. A.
    Mukhopadhyay, P.
    Lerzo, G.
    Pivot, X.
    Bosserman, L. D.
    Mullaney, B.
    Vahdat, L.
    Hortobagyi, G. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 42S - 42S
  • [6] Phase III trial of capecitabine (Xeloda®) plus bevacizumab (Avastin™) versus capecitabine alone in women with metastatic breast cancer (MBC) previously treated with an anthracycline and a taxane.
    Miller, KD
    Rugo, HS
    Cobleigh, MA
    Marcom, PK
    Chap, LI
    Holmes, FA
    Fehrenbacher, L
    Overmoyer, BA
    Reimann, JD
    Vassel, AV
    Langmuir, VK
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S37 - S37
  • [7] Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane (vol 28, pg 3256, 2010)
    Sparano
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07) : 947 - 947
  • [8] Capecitabine monotherapy in advanced breast cancer resistant to anthracycline and taxane: A meta-analysis
    Jiang, Zhansheng
    Yang, Yanfang
    Li, Ling
    Yue, Zhensong
    Lan, Lan
    Pan, Zhanyu
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S957 - S963
  • [9] Phase I/II study of ixabepilone plus capecitabine in anthracycline-pretreated/resistant and taxane-resistant metastatic breast cancer
    Bunnell, Craig
    Vahdat, Linda
    Schwartzberg, Lee
    Gralow, Julie
    Klimovsky, Judith
    Poulart, Valerie
    Peck, Ronald
    Thomas, Eva
    CLINICAL BREAST CANCER, 2008, 8 (03) : 234 - 241
  • [10] Capecitabine and vinorelbine in patients with metastatic breast cancer previously treated with anthracycline and taxane
    Ahn, JH
    Kim, SB
    Kim, TW
    Ahn, SH
    Kim, SM
    Park, JM
    Lee, JS
    Kang, YK
    Kim, WK
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2004, 19 (04) : 547 - 553
12345